XML 67 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) - USD ($)
 1 Months Ended 3 Months Ended
Jan. 15, 2020
Feb. 29, 2020
Jan. 31, 2020
Dec. 23, 2019
Mar. 31, 2020
May 31, 2020
Apr. 30, 2020
Dec. 31, 2019
May 14, 2019
Feb. 01, 2019
Stockholders Equity Note [Line Items]                    
Preferred stock, shares authorized         7,013,600     7,013,600    
Preferred stock, par value         $ 0.0001     $ 0.0001    
Preferred stock, shares issued                
Preferred stock, shares outstanding                
Payment is reflected as a liability         $ 25,000          
Authorized common stock         31,250,000     250,000,000    
Common stock, par value         $ 0.0001     $ 0.0001    
Common stock, shares authorized         250,000,000     250,000,000    
Common stock, shares issued         4,623,582     3,619,658    
Common stock, shares outstanding         4,623,582     3,619,658    
Recognized compensation expense         $ 318,473          
Subsequent Event [Member]                    
Stockholders Equity Note [Line Items]                    
Authorized common stock           250,000,000        
Restricted common stock shares             90,000      
Series D Preferred Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Preferred stock, shares authorized         2,000,000     2,000,000    
Preferred stock, par value         $ 0.0001     $ 0.0001    
Preferred stock, shares issued         547,780     454,546    
Preferred stock, shares outstanding         547,780     454,546    
Preferred Stock as consideration for waivers of penalties         106,134          
Investor agreed to purchase units         2,750          
Gross proceeds         $ 50,000          
Investor paid         $ 25,000          
Shares issued         161,250          
Preferred shares converted         12,900          
Aggregate additional shares               106,134    
Shares issued   161,250                
Conversion of shares   12,900                
Series E Preferred Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Preferred stock, shares authorized         775,000     775,000    
Preferred stock, par value         $ 0.0001     $ 0.0001    
Preferred stock, shares issued         731,845     734,986    
Preferred stock, shares outstanding         731,845     734,986    
Shares issued     39,260              
Preferred shares converted     3,141              
Included in accrued expenses         $ 308,893          
Shares issued     39,260              
Conversion of shares     3,141              
Series F Preferred Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Preferred stock, shares authorized         200,000     200,000    
Preferred stock, par value         $ 0.0001     $ 0.0001    
Preferred stock, shares issued         75,496     139,768    
Preferred stock, shares outstanding         75,496     139,768    
Shares issued   803,414                
Preferred shares converted   64,272                
Included in accrued expenses         $ 308,893          
Shares issued   803,414                
Conversion of shares   64,272                
Preferred Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Preferred stock, shares authorized         10,000,000     10,000,000    
Preferred stock, par value         $ 0.0001     $ 0.0001    
Preferred stock, shares issued         1,355,121     1,329,300    
Preferred stock, shares outstanding         1,355,121     1,329,300    
Owed approximately penalties               $ 6,000,000    
Value of shares issued               1,929,516    
Included in accrued expenses         $ 308,893     $ 2,238,314    
Common Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Restricted common stock                 $ 451,170 $ 43,423
Recognized compensation expense         $ 12,665          
Common stock, description       The Company granted to a consultant 312,500 restricted stock units (the "RSUs") pursuant to a consultant agreement. The RSUs vest 63,500 upon grant with the balance vesting monthly in equal installments beginning January 1, 2020 and ending November 1, 2020, subject to the consultants continued service to the Company on each vesting date. The RSU award has been valued at $343,750 and compensation expense will be recorded over the respective vesting periods. We recognized compensation expense of $74,999 during the three months ended March 31, 2020.            
Restricted common stock, description Pursuant to the agreement the Company agreed to issue 30,000 shares of restricted common stock, earned monthly over the three month term of the agreement. The shares are fully vested upon issuance and have been valued at $45,500. The shares have not been issued at March 31, 2020. We have accrued compensation expense of $39,000 at March 31, 2020.     The Company entered into a consulting agreement. Pursuant to the agreement the Company agreed to issue 60,000 shares of restricted common stock, plus a payment of $15,000. The shares are fully vested upon issuance and have been valued at $75,000. The shares have not been issued at March 31, 2020. We have accrued compensation expense of $31,250 for the share portion of the agreement and $6,250 for the cash portion at March 31, 2020.            
Restricted common stock shares 30,000                  
Common Stock [Member] | Subsequent Event [Member]                    
Stockholders Equity Note [Line Items]                    
Authorized common stock           31,250,000